13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001596452
Total reported value
$131.7M
$131.7M
47 檔
162.2%
According to the latest 13F quarterly dataset, Sivik Global Healthcare LLC managed an equity portfolio of $131.7M at the end of Q1 2024, spanning 47 distinct U.S. exchange-listed positions.
During Q1 2024, Sivik Global Healthcare LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Put - Spy 100 @ 505 Exp 04/19/2024 | Stock-Other | 35.52% | — | — | |
| 2 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 6.67% | — | +121.26% | |
| 3 | LLY | Eli Lilly & Co | Stock-Healthcare | 2.92% | — | +6.67% | |
| 4 | NVO | Novo-nordisk A/s-spons Adr | Stock-Healthcare | 2.78% | — | +2.78% | |
| 5 | BSX | Boston Scientific CORP | Stock-Healthcare | 2.17% | — | -15.63% | |
| 6 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 2.11% | — | +29.17% | |
| 7 | SYK | Stryker CORP | Stock-Healthcare | 2.10% | — | -10.71% | |
| 8 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 1.87% | — | -11.11% | |
| 9 | THC | Tenet Healthcare CORP | Stock-Healthcare | 1.85% | — | -48.28% | |
| 10 | MCK | Mckesson CORP | Stock-Healthcare | 1.82% | — | -3.33% | |
| 11 | DHR | Danaher CORP | Stock-Healthcare | 1.76% | — | +20.00% | |
| 12 | UHS | Universal Health Services-b | Stock-Healthcare | 1.71% | — | -40.74% | |
| 13 | RMD | Resmed Inc | Stock-Healthcare | 1.64% | — | +76.81% | |
| 14 | HUM | Humana Inc | Stock-Healthcare | 1.63% | — | +33.33% | |
| 15 | CRL | Charles River Laboratories | Stock-Healthcare | 1.59% | — | — | |
| 16 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.57% | — | — | |
| 17 | SEM | Select Medical Holdings CORP | Stock-Other | 1.41% | — | -20.00% | |
| 18 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 1.38% | — | — | |
| 19 | HCA | Hca Healthcare Inc | Stock-Healthcare | 1.37% | — | -56.25% | |
| 20 | ABT | Abbott Laboratories | Stock-Healthcare | 1.33% | — | -4.76% | |
| 21 | SGRY | Surgery Partners Inc | Stock-Other | 1.33% | — | -5.00% | |
| 22 | BAX | Baxter International Inc | Stock-Healthcare | 1.30% | — | — | |
| 23 | ACHC | Acadia Healthcare Co Inc | Stock-Other | 1.30% | — | -22.22% | |
| 24 | AVTR | Avantor Inc | Stock-Healthcare | 1.28% | — | — | |
| 25 | SNN | Smith & Nephew PLC -spon Adr | Stock-Other | 1.22% | — | +7.89% | |
| 26 | PODD | Insulet CORP | Stock-Healthcare | 1.21% | — | +13.21% | |
| 27 | CAH | Cardinal Health Inc | Stock-Healthcare | 1.18% | — | +12.50% | |
| 28 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 1.18% | — | +4.55% | |
| 29 | EHC | Encompass Health CORP | Stock-Healthcare | 1.16% | — | -33.33% | |
| 30 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 1.16% | — | — | |
| 31 | DXCM | Dexcom Inc | Stock-Healthcare | 1.14% | — | -30.00% | |
| 32 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.08% | — | -12.00% | |
| 33 | WST | West Pharmaceutical Services | Stock-Healthcare | 0.93% | — | — | |
| 34 | BDX | Becton Dickinson And Co | Stock-Healthcare | 0.87% | — | — | |
| 35 | OPCH | Option Care Health Inc | Stock-Healthcare | 0.86% | — | — | |
| 36 | GEHC | GE Healthcare Technology | Stock-Healthcare | 0.85% | — | — | |
| 37 | CI | THE Cigna Group | Stock-Healthcare | 0.85% | — | -42.86% | |
| 38 | NTRA | Natera Inc | Stock-Healthcare | 0.75% | — | — | |
| 39 | MRVI | Maravai Lifesciences Hldgs-a | Stock-Other | 0.74% | — | +77.84% | |
| 40 | RVTY | Revvity Inc | Stock-Healthcare | 0.74% | — | — | |
| 41 | MEDP | Medpace Holdings Inc | Stock-Healthcare | 0.71% | — | — | |
| 42 | CTLTEUR | Catalent Inc | Stock-Other | 0.66% | — | — | |
| 43 | STVN | Stevanato Group S.p.A. | Stock-Other | 0.62% | — | +3.80% | |
| 44 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 0.58% | — | — | |
| 45 | BNTX | Biontech Se-adr | Stock-Other | 0.54% | — | — | |
| 46 | BIIB | Biogen Inc | Stock-Healthcare | 0.51% | — | -59.86% | |
| 47 | GPCR | Structure Therapeutics Inc | Stock-Other | 0.04% | — | — |
According to official SEC Form 13F filings, Sivik Global Healthcare LLC reported a total U.S. public equity portfolio value of $131.7M across 47 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including PUT - SPY 100 @ 505 EXP 04/19/2024, XBI, LLY) accounted for 162.2% of total reported equity market value during Q1 2024.
During Q1 2024, Sivik Global Healthcare LLC's top holdings by market value included PUT - SPY 100 @ 505 EXP 04/19/2024 (35.5%)、XBI (6.7%)、LLY (2.9%). The largest single position, PUT - SPY 100 @ 505 EXP 04/19/2024, represented 35.5% of total portfolio value.
In Q1 2024, Sivik Global Healthcare LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.